Pancreatic Diseases  >>  Erbitux (cetuximab)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Erbitux (cetuximab) / Eli Lilly, EMD Serono
NCT00383149: A Phase II, Trial of Ixabepilone Plus Cetuximab as First Line Therapy for Metastatic Pancreatic Cancer

Completed
2
58
US
Ixabepilone, IXEMPRA®, Erbitux®, BMS-247550, BMS-564717, Cetuximab
R-Pharm
Metastatic Pancreatic Cancer
06/09
06/09
NCT01050426 / 2008-000517-30: A Clinical Study of UFT/Leucovorin, Radiotherapy With or Without Cetuximab Following Induction Gemcitabine Plus Capecitabine in Patients With Locally Advanced Pancreatic Cancer (PERU)

Terminated
2
17
Europe
UFT, Leucovorin, UFT/ Leucovorin + Cetuximab + Radiotherapy
Royal Marsden NHS Foundation Trust, Merck Serono International SA
Pancreatic Cancer
12/14
12/14

Download Options